Addex Therapeutics Ltd (SWX:ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0534
0.00 (0.00%)
At close: Dec 5, 2025

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 36.38K CHF in the quarter ending June 30, 2025, a decrease of -68.45%. This brings the company's revenue in the last twelve months to 167.29K, down -79.93% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.

Revenue (ttm)
167.29K
Revenue Growth
-79.93%
P/S Ratio
39.26
Revenue / Employee
79.27K
Employees
2
Market Cap
6.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024410.04K-1.21M-74.64%
Dec 31, 20231.62M172.23K11.92%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 63.49B
Novartis AG 44.95B
Galderma Group AG 3.73B
Lonza Group AG 7.09B
Alcon 8.12B
Sandoz Group AG 8.42B
Straumann Holding AG 2.58B
Sonova Holding AG 3.85B
Revenue Rankings